Your session is about to expire
← Back to Search
Integrated Care Management for Lupus (Rheum-iCMP Trial)
Rheum-iCMP Trial Summary
This trialwill study lupus patients at BWH to identify those at high risk of adverse outcomes, and offer intensive care management to reduce avoidable ED visits, hospitalizations and improve high quality care.
Rheum-iCMP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Rheum-iCMP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with systemic lupus erythematosus (SLE) by a rheumatologist, based on specific criteria set by the American College of Rheumatology.
- Group 1: Rheum iCMP Wave 1
- Group 2: Rheum iCMP Wave 2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What purpose does this clinical experiment hope to accomplish?
"The purpose of this trial, observed for a period of 12 months before and during the intervention, is to assess the Quality of Lupus Care - SLE Quality Metric Scoring System for Adults. Secondary outcomes include an evaluation on Change in social determinants of health from baseline to 12months using the Partners Healthcare SDH Survey (with no numerical scoring system), Change in global health from baseline to 12 months using PROMIS global health scale short form (scores range 9-45 with higher scores indicating better outcome) and lastly Change in MASRI score (for lupus medications) from baseline to12 months (score range 0"
Is this trial currently accepting participants?
"According to the clinicaltrials.gov records, this medical trial has concluded its recruitment phase and is no longer seeking applicants. The initial posting date was June 21st 2019 with an edit on November 16th 2022, however there are 125 other trials actively recruiting patients at this time."
Share this study with friends
Copy Link
Messenger